Article
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.
Archives of neurology - 1 Jun 2012
Ringman John M, Elashoff David, Geschwind Daniel H, Welsh Brian T, Gylys Karen H, Lee Cathy, Cummings Jeffrey L, Cole Greg M
Abstract excerpt
OBJECTIVE: To study the effect of familial Alzheimer disease (FAD) mutations and APOE genotype on plasma signaling protein levels. DESIGN: Cross-sectional comparison of plasma levels of 77 proteins measured using multiplex immune assays. SETTING: A tertiary referral dementia research center. PARTICIPANTS: Thirty-three persons from families harboring PSEN1 or APP mutations, aged 19 to 59 years. MAIN OUTCOME...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
